Literature DB >> 7952654

Structure-function relationships in the tissue inhibitors of metalloproteinases.

F Willenbrock1, G Murphy.   

Abstract

The tissue inhibitors of metalloproteinases (TIMPs) are proteins that specifically inhibit the matrix metalloproteinases. They consist of two distinct structural and functional domains. In order to elucidate the role of these domains, we have prepared mutants of TIMP-1 and TIMP-2 that lack a C-terminal domain. The N-terminal domain alone is an efficient inhibitor of all the matrix metalloproteinases through interaction with the enzyme catalytic domain. The C-terminal domain has at least two separate enzyme binding sites, one for gelatinase A and the other for stromelysin-1. The rate of inhibition of either enzyme is increased by interaction with the TIMP C-terminal domain. As no conformational change is observed, we propose that the rate enhancement is due to an anchoring effect in which binding of the TIMP C-terminal domain aligns the TIMP N-terminal domain with the enzyme active site. Site-directed mutagenesis of TIMP-1 has demonstrated that the N-terminal amino acids, His7 and Gln9, are important for inhibition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7952654     DOI: 10.1164/ajrccm/150.6_Pt_2.S165

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  15 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.

Authors:  M A Majid; V A Smith; F J Matthews; A C Newby; A D Dick
Journal:  Br J Ophthalmol       Date:  2006-07-12       Impact factor: 4.638

3.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.

Authors:  D C von Bredow; A E Cress; E W Howard; G T Bowden; R B Nagle
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 5.  Computational sequence analysis of the tissue inhibitor of metalloproteinase family.

Authors:  D A Douglas; Y E Shi; Q A Sang
Journal:  J Protein Chem       Date:  1997-05

Review 6.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

7.  Brain distribution and elimination of recombinant human TIMP-1 after cerebral ischemia and reperfusion in rats.

Authors:  Yalian Sa; Jinsong Hao; Divya Samineni; Joseph Clark; Gail Pyne-Geithman; Joseph Broderick; Aigang Lu
Journal:  Neurol Res       Date:  2011-05       Impact factor: 2.448

Review 8.  Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).

Authors:  Marta Lukaszewicz-Zając; Barbara Mroczko; Johannes Kornhuber; Piotr Lewczuk
Journal:  J Neural Transm (Vienna)       Date:  2013-12-24       Impact factor: 3.575

Review 9.  Structural aspects of the metzincin clan of metalloendopeptidases.

Authors:  F Xavier Gomis-Rüth
Journal:  Mol Biotechnol       Date:  2003-06       Impact factor: 2.695

Review 10.  Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus.

Authors:  Toshiaki Endo; Tamotsu Kiya; Taeko Goto; Hirofumi Henmi; Kengo Manase; Hiroyuki Honnma; Tsuyoshi Baba; Shinichi Ishioka; Takuhiro Hayashi; Manabu Chida; Kazuyo Arima; Kiyohiro Yamazaki; Mika Kanaya; Atsushi Azumaguchi; Osamu Moriwaka; Hirofumi Kamiya; Tsuyoshi Saito
Journal:  Reprod Med Biol       Date:  2006-11-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.